To confirm whether ERBB proteins are important in controlling RAS/MAPK and PI3K/AKT signalling pathways, we conducted siRNA-mediated knockdown of EGFR and ERBB3 in EML4-ALK+positive NSCLC cell lines. This evidence concerns the gene ALK and non-small cell lung carcinoma.